World News: 16:04 GMT Wednesday 30th August 2017. [Novartis International AG via Thomson Reuters ONE via SPi World News]
Novartis International AG Novartisfirst ever FDA approval for a CAR-T cell therapy CTL019 for children and young with B-cell ALL that is refractory or has relapsed at least twice and transmitted by N asdaq C...
Thomson Reuters: 16:04 GMT Wednesday 30th August 2017
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.